Biotricity (OTCMKTS:BTCY) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS

Biotricity (OTCMKTS:BTCY) released its quarterly earnings data on Friday. The company reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.05, Zacks reports.

Biotricity Stock Up 7.9%

Shares of BTCY traded up $0.04 during mid-day trading on Friday, hitting $0.57. 21,604 shares of the company’s stock were exchanged, compared to its average volume of 39,037. The stock has a market cap of $15.28 million, a price-to-earnings ratio of -2.72 and a beta of 1.08. The firm has a fifty day moving average of $0.59 and a two-hundred day moving average of $0.52. Biotricity has a twelve month low of $0.23 and a twelve month high of $0.83.

About Biotricity

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.